Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CKS1B | P61024 | 1/20 | 0.46 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1355901 | 0.82 | CYP4A11 (0.47) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL10366045 | 0.76 | CA1 (0.57) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL542559 | 0.76 | CA1 (0.61) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL30232935 | 0.76 | CA1 (0.61) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL10680744 | 0.75 | ALDH1A1 (0.56) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL8318942 | 0.74 | ALDH1A1 (0.62) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL8408482 | 0.74 | HPGD (0.70) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL8326821 | 0.72 | HPGD (0.60) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL2315368 | 0.72 | CA1 (0.59) | ALDH1A1HPGDTP53ALOX15ALOX12 | |
| SCHEMBL20860908 | 0.72 | CA1 (0.59) | ALDH1A1HPGDTP53ALOX15ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012098560-A2 | PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST | MSN LABORATORIES LIMITED (IN) | 2012-07-26 | — | — | WO | claimed |
| WO-2012098560-A2 | PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST | MSN LABORATORIES LIMITED (IN) | 2012-07-26 | — | — | WO | disclosed |
| WO-2011158257-A1 | PREPARATION PROCESS OF FESOTERODINE AND INTERMEDIATES | PANACEA BIOTEC LTD (IN) | 2011-12-22 | — | — | WO | disclosed |
| WO-2011141932-A2 | PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS | INTAS PHARMACEUTICALS LIMITED (IN) | 2011-11-17 | — | — | WO | disclosed |
| US-20110282094-A1 | PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS | INTAS PHARMACEUTICALS LIMITED (IN) | 2011-11-17 | — | — | US | disclosed |
| EP-1230209-B3 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | UCB PHARMA GMBH (DE) | 2011-10-05 | — | — | EP | disclosed |
| JP-2010180242-A | STABLE SALT OF NOVEL DERIVATIVE OF 3,3-DIPHENYLPROPYLAMINES | UCB PHARMA GMBH | 2010-08-19 | — | — | JP | disclosed |
| JP-2007137895-A | STABLE SALT OF NEW DERIVATIVE OF 3, 3-DIPHENYL PROPYLAMINES | SCHWARZ PHARMA AG | 2007-06-07 | — | — | JP | disclosed |
| US-6858650-B1 | For therapy of urinary incontinence | SCHWARZ PHARMA AG (DE) | 2005-02-22 | — | — | US | disclosed |
| US-6858650-B1 | For therapy of urinary incontinence | SCHWARZ PHARMA AG (DE) | 2005-02-22 | — | — | US | disclosed |
| EP-1230209-A2 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | SCHWARZ PHARMA AG (DE) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001035957-A3 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | SANOL ARZNEI SCHWARZ GMBH (DE) | 2001-12-27 | — | — | WO | disclosed |
| WO-2001035957-A8 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | SANOL ARZNEI SCHWARZ GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
| WO-2001035957-A1 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | SANOL ARZNEI SCHWARZ GMBH (DE) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282094-A1 | PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS | HPD, COMT, PNMT | ALDH1A1 257/4885HPGD 359/4885TP53 4106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.